SCHEMBL22628079

SCHEMBL22628079

Cc1cc(OCC(=O)NC23CCC(NC(=O)c4cc(C(F)F)no4)(CC2)C[C@@H]3O)ccc1Cl

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ SENP2 Q9HC62 4/20 0.44
▸ MAPT P10636 3/20 0.41
▸ THRB P10828 1/20 0.41
▸ POLB P06746 2/20 0.40
▸ ALPL P05186 1/20 0.40
▸ ALPI P09923 1/20 0.40
▸ ALPG P10696 1/20 0.40
▸ ALDH1A1 P00352 1/20 0.39
▸ NPC1 O15118 1/20 0.39
▸ RAB9A P51151 1/20 0.39
▸ GAA P10253 1/20 0.39
▸ MEN1 O00255 1/20 0.39
▸ PKM P14618 1/20 0.39
▸ KMT2A Q03164 1/20 0.39
▸ TSHR P16473 2/20 0.39
▸ LMNA P02545 1/20 0.39
▸ MAPK1 P28482 1/20 0.39
▸ SENP1 Q9P0U3 3/20 0.38
▸ ATF4 P18848 1/20 0.38
▸ MCL1 Q07820 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL32689691 1.00 SENP2 (0.44) SENP2MAPTTHRBPOLBALPL
SCHEMBL22437035 0.94 ATF4 (0.37) SENP2MAPTTHRBALDH1A1GAA
SCHEMBL32689699 0.94 THRB (0.41) SENP2MAPTTHRBPOLBALDH1A1
SCHEMBL19556219 0.94 ATF4 (0.37) SENP2MAPTTHRBALDH1A1GAA
SCHEMBL19555951 0.92 ATF4 (0.45) ATF4
SCHEMBL19556229 0.92 ATF4 (0.45) ATF4
SCHEMBL22956629 0.91 ATF4 (0.38) MAPTALDH1A1NPC1MEN1KMT2A
SCHEMBL22628519 0.90 ATF4 (0.47) SENP2MAPTNPC1RAB9ATSHR
SCHEMBL22628167 0.90 MAPT (0.38) MAPTTHRBPOLBALDH1A1GAA
SCHEMBL22628052 0.90 USP2 (0.36) SENP2MAPTATF4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20200345727-A1 MODULATORS OF THE INTEGRATED STRESS PATHWAY ABBVIE INC. 2020-11-05 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20200345727-A1 MODULATORS OF THE INTEGRATED STRESS PATHWAY ATF4, ATF1, DDIT3 SENP2 3515/4885MAPT 3293/4885THRB 1462/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback